Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Tyrosine Protein Kinase SYK-Related Gene Signature in Baseline Immune Cells Associated with Adjuvant Immunotherapy-Induced Immune-Related Adverse Events in Melanoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 21, 2024
Correction: Tumor immunogenomic signatures improve a prognostic model of melanoma survival.
Journal: Journal of translational medicine
Published: April 02, 2023
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 13, 2023
Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
Journal: Journal for immunotherapy of cancer
Published: October 25, 2022
A genome-wide association study of germline variation and melanoma prognosis.
Journal: Frontiers in oncology
Published: September 22, 2022
Tumor immunogenomic signatures improve a prognostic model of melanoma survival.
Journal: Journal of translational medicine
Published: November 23, 2020
Germline Genetics in Immuno-oncology: From Genome-Wide to Targeted Biomarker Strategies.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 11, 2019
Germline genetic host factors as predictive biomarkers in immuno-oncology.
Journal: Immuno-oncology technology
Published: September 05, 2019
Immunomodulatory germline variation associated with the development of multiple primary melanoma (MPM).
Journal: Scientific reports
Published: March 25, 2019
Last Updated: 09/26/2026